Fabrication of nanofibrous mat surrounded hydrogel scaffold as an encapsulation device for encapsulating pancreas β cells.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 12 2022
19 12 2022
Historique:
received:
26
06
2022
accepted:
05
12
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
22
12
2022
Statut:
epublish
Résumé
The main barriers to cells or organ transplantation such as pancreatic β-cells are the need for lifelong immune suppression and the shortage of donors. It may be overcome via cell encapsulation and transplantation techniques. Hydrogels provide a suitable ECM-like microenvironment for cells to adhere, survive, and function, while weakly performing as an immune barrier. In this study, we aimed to macro-encapsulate islet cells in a dual encapsulation device with collagen hydrogel and PCL nanofiber to provide an immune-isolated environment for cells to function more efficiently, where immune cells are not allowed to enter but oxygen, insulin, and nutrients can pass through. PCL thin mats with the pores diameter of 500 nm were synthesized by electrospinning and characterized by scanning electron microscope, porosity measurement, tensile strength test, and contact angle measurement. Collagen hydrogel was fabricated by extracting collagen fibers from rat tail tendons and solving them in acetic acid. β-cells (CRI-D2 cell line) encapsulated after neutralizing collagen solution (pH ≈ 7.4). Cell-collagen gel complex was poured into the nanofibrous mat packets to fabricate the whole device. Histology evaluation, cell viability, and cell function tests were done in 10 days. Live/dead assay of Cri-D2 cells encapsulated within the device showed that cells have diffuse distribution at the core of the hydrogel and the device. Also, cluster formation was seen and shows these cells can live in groups. To identify cells' function within the device in these 10 days samples' supernatant insulin level was measured by chemiluminescent immunoassay. It just showed a positive result for existing insulin within the medium. Based on our results, this device presents adequate features to be a good immune-isolation device for cell transplanting.
Identifiants
pubmed: 36535972
doi: 10.1038/s41598-022-25736-8
pii: 10.1038/s41598-022-25736-8
pmc: PMC9763327
doi:
Substances chimiques
Hydrogels
0
Collagen
9007-34-5
Insulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21910Informations de copyright
© 2022. The Author(s).
Références
Biomed Microdevices. 2007 Feb;9(1):91-9
pubmed: 17106639
Sci Rep. 2018 Jul 16;8(1):10694
pubmed: 30013127
Adv Drug Deliv Rev. 2000 Aug 20;42(1-2):29-64
pubmed: 10942814
Front Immunol. 2018 Jun 12;9:1354
pubmed: 29963051
Diabetes Care. 2018 May;41(5):963-970
pubmed: 29475843
Adv Drug Deliv Rev. 2019 Apr;144:148-161
pubmed: 31491445
J Biomater Sci Polym Ed. 2008;19(5):623-34
pubmed: 18419941
Small. 2022 Feb;18(8):e2104899
pubmed: 34897997
J Biomed Mater Res A. 2017 Oct;105(10):2865-2874
pubmed: 28608414
Tissue Eng Part B Rev. 2014 Dec;20(6):683-96
pubmed: 24923709
J Biomed Mater Res A. 2020 Jan;108(1):127-135
pubmed: 31515867
Colloids Surf B Biointerfaces. 2018 Jul 1;167:448-456
pubmed: 29709829
Am J Transplant. 2016 Feb;16(2):509-17
pubmed: 26433206
Nat Protoc. 2006;1(6):2753-8
pubmed: 17406532
Diabetes Care. 2003 Jun;26(6):1902-12
pubmed: 12766131
Adv Drug Deliv Rev. 2000 Aug 20;42(1-2):65-80
pubmed: 10942815
Sci Rep. 2019 May 31;9(1):8145
pubmed: 31148602
J Biomater Sci Polym Ed. 2018 May - Jun;29(7-9):863-893
pubmed: 29053081
J Polym Sci B Polym Phys. 2011 Jun 15;49(12):832-864
pubmed: 21769165
Sci Rep. 2017 Nov 22;7(1):16033
pubmed: 29167483
MRS Bull. 2010 May;35(5):382-388
pubmed: 21151848
Environ Health Perspect. 1997 Sep;105 Suppl 5:1261-3
pubmed: 9400735
Curr Opin Pharmacol. 2017 Oct;36:66-71
pubmed: 28865291
J Mater Sci Mater Med. 2019 Oct 10;30(10):115
pubmed: 31599365
Sci Transl Med. 2021 Jun 2;13(596):
pubmed: 34078744
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14452-9
pubmed: 26598661
BMJ. 2018 Apr 18;361:k1310
pubmed: 29669716
Nat Mater. 2015 Jun;14(6):643-51
pubmed: 25985456
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):364-372
pubmed: 30641727
Curr Diab Rep. 2017 Jun;17(6):37
pubmed: 28432571
Anal Chim Acta. 2015 Jan 1;853:95-115
pubmed: 25467452
AAPS PharmSciTech. 2017 Feb;18(1):72-81
pubmed: 26883261
Future Sci OA. 2019 Oct 10;5(9):FSO418
pubmed: 31608157
Nat Rev Endocrinol. 2017 May;13(5):268-277
pubmed: 27834384
J Biomed Mater Res B Appl Biomater. 2008 Jan;84(1):34-48
pubmed: 17477388
Adv Drug Deliv Rev. 2019 Jan 15;139:92-115
pubmed: 29719210
J Diabetes Sci Technol. 2008 Sep;2(5):768-77
pubmed: 19885259
Injury. 2012 May;43(5):553-72
pubmed: 21269624
Stem Cells Transl Med. 2019 Mar;8(3):209-214
pubmed: 30417988
Diabetes Care. 2009 Jul;32(7):1335-43
pubmed: 19564476
Biomaterials. 2015 Jan;37:40-8
pubmed: 25453936
J Microsc Ultrastruct. 2017 Jan-Mar;5(1):1-8
pubmed: 30023231
Biomaterials. 2016 Oct;104:87-103
pubmed: 27449946
Stem Cells Transl Med. 2017 Apr;6(4):1053-1058
pubmed: 28186705